Overall, in our present study we confirmed that inhibiting ATM increased cytotoxicity of PARP inhibitor in breast cancer cell lines, and demonstrated for the first time that depleting 53BP1 reduced this cytotoxicity. The gene discussed is TP53BP1; the disease is breast carcinoma.